Don't miss the industry's most comprehensive event!
KEYNOTE PRESENTATION:
Mechanism - Driven Approaches to Molecular Targeted Cancer Drug Discovery
Robert A. Copeland, Ph.D., Vice President, Biology,
Oncology Center of Excellence in Drug Discovery,
GlaxoSmithKline Pharmaceuticals
TOPICS TO BE DISCUSSED:
- Non-ATP Competitive Inhibitors
- Targeting Tumors
- Screening and Lead Optimization
- Expanding the Therapeutic Scope
- Structure – Based Design